
Welcome to Innate Pharma | Innate Pharma
Oct 14, 2025 · Innate Pharma is a global clinical-stage oncology-focused biotech company. Our ambition is to establish innovative approaches to make a lasting difference to patients’ lives by …
Company profile - Innate Pharma
Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and …
Pipeline overview - Innate Pharma
Innate Pharma is developing an innovative pipeline of antibody-based therapeutics by leveraging the body’s immune system to improve outcomes for patients suffering from cancer and other …
Bienvenue chez Innate Pharma | Innate Pharma
Innate Pharma est une société de biotechnologies au stade clinique spécialisée en immuno-oncologie. Notre ambition est de mettre en place des approches innovantes pour améliorer …
Investor Relations - Innate Pharma
Nov 5, 2025 · Innate Pharma S.A is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic …
All press releases - Innate Pharma
Aug 1, 2025 · Innate Pharma announces FDA clearance to proceed with TELLOMAK 3, a confirmatory Phase 3 trial of lacutamab in CTCL November 10, 2025
Our history - Innate Pharma
Innate Pharma was founded in 1999 by a group of immunologists, four European Scientists - pioneers in the field of innate immunity (Alessandro Moretta, Marc Bonneville, Jean-Jacques …
Innate Pharma announces €15m investment by Sanofi
Apr 24, 2025 · “ We welcome Sanofi’s strategic investment in Innate, which further reinforces the strength of our collaboration.
Our scientific approach - Innate Pharma
Oct 3, 2019 · Innate Pharma has specialized in immunotherapy since its inception in 1999. Recent developments in immunotherapy have focused on the generation of a tumor antigen …
Innate Pharma reports first quarter 2025 business update and …
Mar 31, 2025 · Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today reported its consolidated financial results for the quarter ending March 31, …